An educational resource of the Ocular Immunology and Uveitis Foundation

Massachusetts Eye Research and Surgery Institution
About Us Patient Information Medical Professionals Services

Low Vision | Our Medical Advisor | Member Guidelines | Ask Dr. Foster | Uveitis Glossary | Pars Planitis Forum | Contact Us

Home Page
    > Glenn's Rheumatology Reading Corner
        > Visual outcome of JRA-associated uveitis in adults
New Topic

<< Prev Topic | Next Topic >>
Author
Comment
Webmaster
Administrator
(4/8/07 12:28 pm)


Visual outcome of JRA-associated uveitis in adults
Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ozdal PC, Vianna RN, Deschenes J. Ocul Immunol Inflamm. 2005 Feb;13(1):33-8 (Abstract) (Related articles)

McGill University, Department of Ophthalmology, Uveitis Service, Montreal Canada.

ABSTRACT

PURPOSE:
Juvenile rheumatoid arthritis (JRA) is the systemic disease most frequently associated in childhood uveitis. The disease may cause several ocular complications, visual impairment, and blindness. Recent studies revealed a more favorable ocular prognosis. Our purpose was to analyze the long-term visual outcome of JRA-associated uveitis.

METHODS:
Ocular complications and visual outcome in adult patients with JRA-associated uveitis were evaluated. Among 18 patients included in the study, uveitis was bilateral in 12 (66.7%) and unilateral in six (33.3%), for a total of 30 eyes with ocular involvement.

RESULTS:
The mean durations of JRA and its associated uveitis were 24.9 and 20.5 years, respectively. All eyes (100%) had at least one ocular complication. The most frequently observed ocular complications were cataract (83.3%), band keratopathy (60%), posterior synechia (46.7%), glaucoma (33.3%), hypotony (16.7%), and macular pathology (13.3%). Final visual acuity was impaired in 40% of the eyes, poor in 20%, and totally lost in 10%. Therefore, 70% of the eyes were either visually handicapped or totally blind. Most eyes underwent at least one surgical procedure. Inflammation was active at last examination in 63.3% of eyes. All patients were still treated topically and with systemic NSAID. Sixty-one percent of the patients were using an immunosuppressive agent.

CONCLUSION:
JRA-associated uveitis still has a severe course and blinding potential. Patients suffer from uveitis and its complications even during the adulthood period. However, because our series represents a more severe subset of the disease, the outcome may be poorer than that of some other outcome studies.

<< Prev Topic | Next Topic >>


Topic Control Image Topic Commands
Click to receive email notification of replies Click to receive email notification of replies
Click to stop receiving email notification of replies Click to stop receiving email notification of replies
jump to:

- Home Page - Glenn's Rheumatology Reading Corner - Ocular Immunology and Uveitis Foundation, URL>>www.uveitis.org -

Low Vision Instructions | About Our Medical Advisor | Uveitis  Glossary | Office Directions  |  Contact Us



Powered By ezboard® Ver. 7.32
Copyright ©1999-2007 ezboard, Inc.